Rome, July 16, 2025 – Spazio Cargo

When we talk about innovation in medicine, we often picture machines, numbers and algorithms.
But what took place in Rome at Spazio Cargo was something far more human.

It was a shared moment. A space where science met emotion, where data met identity.
At the heart of the evening were people. Their stories. Their courage. Their turning points.

Real individuals stood up and shared how their lives had changed thanks to DMA®, to early insights, timely action, and the power to listen to their own bodies.

The event was moderated by journalist Luca Lisci, Editor-in-Chief of IDA – The Voice of the Decision Science Alliance. With clarity and care, he guided the audience through stories, science and the vision of a new healthcare future.

Guests stepped into an immersive journey.
They watched short films. Shared conversation over an aperitivo. Asked big questions.
The room was filled with energy, empathy and a shared sense of possibility.

At the center of it all was DMA®, Deep Metabolic-Processes Assessment: Math Biology’s AI-native, non-invasive technology that detects early metabolic shifts before symptoms appear, before disease takes hold.

DMA® doesn’t wait for illness. It listens to metabolism, the body’s silent language.
Every cell speaks. Every organ responds. With DMA®, we’re learning to hear what the body has been saying all along.

The Founders & Team Speak

Raffaele Maccioni, Co-founder and CEO, opened the evening by sharing the roots of Math Biology. The company was born from the need to read early biological signals through math and systems thinking.

Giuseppe Sgro, Co-founder and Director of Clinical R&D, spoke of real people behind the numbers. Metabolic data, he explained, often holds the key to symptoms no one could previously explain.

Francesca Antonella Aiello, R&D Coordinator, translated the complexity of the tech into something clear and tangible. By reading how the body processes energy in real time, DMA® helps reveal how it’s coping and what might soon go wrong.

CFO Alessandro Cascia highlighted the value beyond the clinical: reducing long-term healthcare costs, accelerating diagnosis and improving lives while creating sustainable market growth.

Maria Cristina Caracciolo, Head of Legal & Corporate Affairs, offered a concrete view on regulation, saying Math Biology is already aligned with national and European healthcare systems and ready to scale.

Maddalena Mazzali, Community Manager, brought it all back to people. She spoke of awareness, trust and how building a participatory health culture is the only way forward.

Real Stories. Real People. Real Impact.

Throughout the evening, the technology came alive through testimony.

Guests listened to people who had lived through turning points. Some had gone in for a routine check-up. Others were struggling with years of fatigue or pain. In many cases, DMA® helped uncover the root cause silent tumors, toxic exposures, metabolic imbalances and pointed the way to early treatment.

There were no slogans. Just stories.
Stories of prevention, precision and personal breakthroughs.

Behind each one was the same truth:
health is not just about fixing what’s broken.
It’s about understanding what’s changing before it’s too late.

A Shared Mission: Health That Starts Earlier

This gathering wasn’t just about investment.
It was about shared intention.

Doctors, researchers, investors, patients all part of the same mission:
To shift healthcare from reactive to proactive.
To build a future where listening to your body is easy, early, and empowering.

DMA® is designed for everyone.
For clinics in underserved communities. For doctors seeking clarity in complex cases.
For people who want to take control of their health before symptoms appear.

The evening reminded everyone that true innovation is not just technological.
It’s cultural. It’s human. And it starts with listening.

Health is not a privilege.
It’s your most vital data.
It’s time we learn how to use it.